Avenir® vs. AxiumTM Coils for the Treatment of Intracranial Aneurysms: Results of a Multicenter Randomized Controlled Trial With Short-Term Follow-Up
Wei Li(Harbin Medical University), Youxiang Li(Capital Medical University), Huaizhang Shi(Harbin Medical University), Xiang Xu(Yanbian University), Honglei Wang(Jilin University), Yuxiang Gu(Fudan University), Hans Henkes(Klinikum Stuttgart), Hongqi Zhang(Central South University), Ming Ye(First Affiliated Hospital of Bengbu Medical College), Yuanli Zhao(Chinese Academy of Medical Sciences & Peking Union Medical College), Alexandru Cimpoca(Klinikum Stuttgart), Feng Wang(First Affiliated Hospital of Dalian Medical University), Hongming Ji(Shanxi Medical University)
Cited by 9
Related Papers
Trial of Thrombectomy 6 to 24 Hours after Stroke Due to Basilar-Artery Occlusion
|New England Journal of Medicine|2022|707
Estimated Burden of Stroke in China in 2020
|JAMA Network Open|2023|595
China stroke surveillance report 2021
|Military Medical Research|2023|554
METTL3/IGF2BP3 axis inhibits tumor immune surveillance by upregulating N6-methyladenosine modification of PD-L1 mRNA in breast cancer
|Molecular Cancer|2022|498
Epidemiology of Carbapenem-Resistant Enterobacteriaceae Infections: Report from the China CRE Network
|Antimicrobial Agents and Chemotherapy|2017|472